| abstract |
The present invention comprises compounds of Formula I. n n n n n n n n n n wherein:n nX, A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , and R 3 are defined in the specification.n n The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORĪ³t activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1. |